Watchlist Price Alert

Inhibikase Therapeutics I... (IKT)

NASDAQ: IKT · Real-Time Price · USD

2.05

-0.05 (-2.38%)

At close: May 09, 2025, 10:42 AM

Inhibikase Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	260.5K	123.44K	3.1M	698.47K	1.12M	4.04M	2.06M	967.39K
Cost of Revenue	n/a	13.62M	6.72K	11.36M	893.8K	2.55M	3.65M	1.76M	846.39K
Gross Profit	n/a	-13.36M	116.72K	-8.26M	-195.33K	-1.43M	393.85K	305.25K	121K
Operating Income	-28.59M	-20.09M	-18.13M	-14.77M	-2.82M	-5.7M	-2.12M	-405.13K	-613.29K
Interest Income	1.07M	1.06M	74.45K	19.92K	29.4K	24.84K	n/a	30.95K	15.45K
Pretax Income	-27.52M	-19.03M	-18.05M	-14.79M	-2.85M	-5.72M	-2.15M	-436.07K	-628.74K
Net Income	-27.52M	-19.03M	-17.91M	-14.81M	-2.88M	-5.75M	-2.15M	-436.07K	-628.74K
Selling & General & Admin	11.38M	6.73M	6.22M	6.51M	2.62M	4.27M	2.52M	710.38K	734.29K
Research & Development	17.18M	13.62M	12.03M	11.36M	893.8K	2.55M	3.65M	1.76M	846.39K
Other Expenses	n/a	-13.62M	-123.44K	-3.1M	-698.47K	-1.12M	n/a	n/a	n/a
Operating Expenses	28.59M	6.73M	18.13M	14.77M	2.82M	5.7M	2.12M	2.47M	734.29K
Interest Expense	n/a	n/a	74.45K	19.92K	29.4K	24.84K	30.33K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	28.59M	20.35M	18.13M	14.77M	2.82M	5.7M	2.12M	2.47M	1.58M
Income Tax Expense	n/a	n/a	-148.91K	19.92K	29.4K	24.84K	-161.14K	-405.13K	-15.45K
Shares Outstanding (Basic)	23.71M	5.33M	4.2M	3.03M	1.68M	1.72M	1.34M	1.72M	1.3M
Shares Outstanding (Diluted)	23.71M	5.33M	4.2M	3.03M	1.68M	1.72M	1.34M	1.72M	1.3M
EPS (Basic)	-1.16	-3.57	-4.26	-4.88	-1.72	-3.34	-1.61	-0.25	-0.48
EPS (Diluted)	-1.16	-3.57	-4.26	-4.88	-1.72	-3.34	-1.61	-0.25	-0.48
EBITDA	-27.49M	-19.91M	-18.12M	-14.77M	-2.82M	-5.7M	n/a	n/a	n/a
EBIT	n/a	-20.09M	-18.13M	-14.77M	-2.82M	-5.7M	-2.12M	-405.13K	-613.29K
Depreciation & Amortization	n/a	177.4K	6.72K	14.77M	2.82M	5.7M	2.12M	405.13K	613.29K